A radical explanation for glucose-induced beta cell dysfunction
- PMID: 14679173
- PMCID: PMC297003
- DOI: 10.1172/JCI20501
A radical explanation for glucose-induced beta cell dysfunction
Abstract
The development of type 2 diabetes requires impaired beta cell function. Hyperglycemia itself causes further decreases in glucose-stimulated insulin secretion. A new study demonstrates that hyperglycemia-induced mitochondrial superoxide production activates uncoupling protein 2, which decreases the ATP/ADP ratio and thus reduces the insulin-secretory response. These data suggest that pharmacologic inhibition of mitochondrial superoxide overproduction in beta cells exposed to hyperglycemia could prevent a positive feed-forward loop of glucotoxicity that drives impaired glucose tolerance toward frank type 2 diabetes.
Figures


Comment on
-
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction.J Clin Invest. 2003 Dec;112(12):1831-42. doi: 10.1172/JCI19774. J Clin Invest. 2003. PMID: 14679178 Free PMC article.
Similar articles
-
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction.J Clin Invest. 2003 Dec;112(12):1831-42. doi: 10.1172/JCI19774. J Clin Invest. 2003. PMID: 14679178 Free PMC article.
-
Overexpression of short heterodimer partner recovers impaired glucose-stimulated insulin secretion of pancreatic beta-cells overexpressing UCP2.J Endocrinol. 2004 Oct;183(1):133-44. doi: 10.1677/joe.1.05675. J Endocrinol. 2004. PMID: 15525581
-
Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism.Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E1008-18. doi: 10.1152/ajpendo.00008.2004. Epub 2004 Jul 20. Am J Physiol Endocrinol Metab. 2004. PMID: 15265758
-
The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes.Cell. 2001 Jun 15;105(6):705-7. doi: 10.1016/s0092-8674(01)00389-0. Cell. 2001. PMID: 11440712 Review. No abstract available.
-
Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion.N Engl J Med. 2001 Dec 13;345(24):1772-4. doi: 10.1056/NEJM200112133452412. N Engl J Med. 2001. PMID: 11742055 Review. No abstract available.
Cited by
-
Antioxidant strategies in the management of diabetic neuropathy.Biomed Res Int. 2015;2015:515042. doi: 10.1155/2015/515042. Epub 2015 Mar 2. Biomed Res Int. 2015. PMID: 25821809 Free PMC article. Review.
-
Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome.Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. doi: 10.1242/dmm.003251. Epub 2009 Oct 19. Dis Model Mech. 2009. PMID: 19841237 Free PMC article.
-
Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties.Diabetol Metab Syndr. 2014 Mar 20;6(1):42. doi: 10.1186/1758-5996-6-42. Diabetol Metab Syndr. 2014. PMID: 24650557 Free PMC article.
-
Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line.Diabetologia. 2007 Feb;50(2):359-69. doi: 10.1007/s00125-006-0462-6. Epub 2006 Dec 7. Diabetologia. 2007. PMID: 17151863
-
Autoregulation of free radicals via uncoupling protein control in pancreatic beta-cell mitochondria.Biophys J. 2010 Jan 20;98(2):207-17. doi: 10.1016/j.bpj.2009.10.012. Biophys J. 2010. PMID: 20338842 Free PMC article.
References
-
- Cowie CC, et al. Prevalence of diabetes and impaired fasting glucose in adults: United States, 1999-2000. JAMA. 2003;290:1702–1703. - PubMed
-
- Narayan KM, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–1890. - PubMed
-
- Norhammar A, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;360:2140–2144. - PubMed
-
- National Diabetes Data Group. 1995. Diabetes in America. 2nd edition. Bethesda, Maryland, USA. NIH Publication no. 95-1468. 1–730.
-
- Minokoshi Y, et al. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J. Biol. Chem. 2003;278:33609–33612. - PubMed